Answers are grounded in this paper and cite their sources.
The article discusses in detail three fairly stable myths about drug interactions of macrolide antibiotic Josamycin, which have become widespread in Russian literature over three decades since the drug product was introduced in Russia: 1) Josamycin does not affect the metabolism of other drugs; 2) Josamycin has a negligible effect on the metabolism of other drugs; 3) Josamycin rarely interacts with other drugs.
No takes yet. Share an insight, caveat, or question.
Бельдиев et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: